Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
12.68
+0.28 (2.22%)
At close: Sep 8, 2026, 4:00 PM EDT
12.75
+0.07 (0.59%)
After-hours: Sep 8, 2026, 7:59 PM EDT
Zevra Therapeutics Market Cap
Zevra Therapeutics has a market cap or net worth of $752.69 million as of September 8, 2026. Its market cap has increased by 49.82% in one year.
Market Cap
752.69M
Enterprise Value
532.62M
1-Year Change
49.82%
Ranking
Category
Stock Price
$12.68
ChartMarket Cap Chart
Since April 16, 2015, Zevra Therapeutics's market cap has increased from $137.80M to $752.69M, an increase of 446.22%. That is a compound annual growth rate of 16.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 752.69M | 49.22% |
| Dec 31, 2025 | 504.40M | 13.30% |
| Dec 31, 2024 | 445.20M | 87.69% |
| Dec 29, 2023 | 237.20M | 49.75% |
| Dec 30, 2022 | 158.40M | -48.50% |
| Dec 31, 2021 | 307.60M | 505.51% |
| Dec 31, 2020 | 50.80M | 303.17% |
| Dec 31, 2019 | 12.60M | -73.25% |
| Dec 31, 2018 | 47.10M | -20.71% |
| Dec 29, 2017 | 59.40M | 37.50% |
| Dec 30, 2016 | 43.20M | -84.95% |
| Dec 31, 2015 | 287.00M | 108.27% |
| Apr 16, 2015 | 137.80M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Monopar Therapeutics | 789.08M |
| Aura Biosciences | 784.01M |
| AgomAb Therapeutics NV | 777.13M |
| Neurogene | 772.44M |
| MapLight Therapeutics | 765.28M |
| Phathom Pharmaceuticals | 754.59M |
| Oculis Holding AG | 751.28M |
| Assembly Biosciences | 745.20M |